Modern Pathology

A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022).  35:2023-2024. 2022

Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification.  35:1944-1954. 2022

Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.  35:1101-1109. 2022

Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.  35:344-351. 2022

TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.  35:376-385. 2022

Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6).  35:289. 2022

Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience.  35:249-255. 2022

A simplified breast cancer prognostic score: comparison with the AJCC clinical prognostic staging system.  34:2141-2147. 2021

Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.  34:2050-2054. 2021

Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.  34:2055-2063. 2021

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.  34:1392-1424. 2021

Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.  34:1167-1184. 2021

Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia (Modern Pathology, (2021), 10.1038/s41379-021-00737-6).  34:1037. 2021

TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.  34:842-850. 2021

Abstracts from USCAP 2021: Gastrointestinal Pathology (311-404)..  34:501-620. 2021

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.  34:660-671. 2021

Prognostic significance of acral lentiginous histologic type in T1 melanoma.  34:572-583. 2021

Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution.  34:291-299. 2021

Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6) 2021

T3 versus T4a staging challenges in deeply invasive colonic adenocarcinomas and correlation with clinical outcomes.  34:131-140. 2021

ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.  33:2564-2579. 2020

Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.  33:2520-2533. 2020

Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution.  33:2499-2506. 2020

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.  33:1746-1752. 2020

Abstracts from USCAP 2020: Dermatopathology (459-522)..  33:602-671. 2020

Editorial.  33:178. 2020

Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.  32:1698-1707. 2019

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.  32:1544-1550. 2019

NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.  32:764-773. 2019

Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus..  1801-1806. 2018

Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.  31:179-197. 2018

Prostate cancer: diagnostic criteria and role of immunohistochemistry.  31:12-21. 2018

Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study..  30:312. 2017

Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndrome.  30:146-156. 2017

Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.  29:788-798. 2016

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.  29:511-515. 2016

Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: A comparative study.  28:1084-1100. 2015

The protective effect of p16 INK4a in oral cavity carcinomas: p16 Ink4A dampens tumor invasion-integrated analysis of expression and kinomics pathways.  28:631-653. 2015

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.  28:612-630. 2015

Dermatopathology.  28:115-128. 2015

Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma..  27:1063-1072. 2014

Clinical heterogeneity of Xp11 translocation renal cell carcinoma: Impact of fusion subtype, age, and stage.  27:875-886. 2014

Sacrococcygeal teratomas: Clinico-pathological characteristics and isochromosome 12p status.  27:562-568. 2014

Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.  26:54-61. 2013

Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.  26:32-43. 2013

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.  25:1543-1549. 2012

Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.  25:893-901. 2012

Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.  24:1521-1529. 2011

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.  24:1511-1520. 2011

Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.  24:1313-1319. 2011

ERG gene rearrangements are common in prostatic small cell carcinomas.  24:820-828. 2011

International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease.  24:26-38. 2011

ERG rearrangement is present in a subset of transition zone prostatic tumors.  23:1499-1506. 2010

TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.  22:1415-1422. 2009

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.  22:1399-1400. 2009

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.  22:1032-1043. 2009

Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.  22:1016-1022. 2009

Testicular mixed germ cell tumors: A morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.  22:1066-1074. 2009

Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma.  22:639-650. 2009

TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.  22:359-365. 2009

Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor.  22:385-392. 2009

Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.  21:1337-1344. 2008

Profiling the expression pattern of GPI transamidase complex subunits in human cancer.  21:979-991. 2008

Sentinel node in melanoma patients: Triple negativity with routine techniques and PCR as positive prognostic factor for survival.  21:438-444. 2008

Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.  19:392-398. 2006

Erythropoietin and erythropoietin receptor expression in human prostate cancer.  18:421-430. 2005

The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.  15:45-49. 2002

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions.  14:1052-1058. 2001

Evaluation of cyclin expression in testicular germ cell tumors: Cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis.  13:667-672. 2000

In vivo cyclin e expression as a marker for early cervical neoplasia.  11:1238-1246. 1998

Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms.  11:963-966. 1998

Heterogeneity of androgen receptor content in advanced prostate cancer.  10:839-845. 1997

Integrated expression of glomerular extracellular matrix proteins and β1 integrins in monoclonal light chain-related renal diseases.  10:485-495. 1997

Giant cell myocarditis: An entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells.  9:1126-1134. 1996

Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.  8:260-265. 1995

Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.  6:733-737. 1993

Florid papillomatosis of the nipple: immunohistochemical and flow cytometric analysis of two cases..  3:288-293. 1990

Immunoreactivity in malignant mesotheliomas with antibodies to basement membrane components and their receptors..  3:11-18. 1990